Acorda therapeutics to regain global commercialization rights to fampyra® by january 2025

Pearl river, n.y.--(business wire)--acorda therapeutics to regain global commercialization rights to fampyra® by january 2025.

ACOR Ratings Summary

ACOR Quant Ranking